z-logo
open-access-imgOpen Access
Unveiling the Potential of Repurposing FDA-Approved Drugs in Pancreatic Cancer
Author(s) -
Matthias Ilmer,
Bernhard W. Renz
Publication year - 2018
Publication title -
journal of molecular biomarkers and diagnosis
Language(s) - English
Resource type - Journals
ISSN - 2155-9929
DOI - 10.4172/2155-9929.1000e128
Subject(s) - repurposing , medicine , pancreatic cancer , drug repositioning , cancer , cancer drugs , pharmacology , intensive care medicine , drug , biology , ecology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom